Key result
Self-monitoring of oral anticoagulation reduces thromboembolic events and does not increase the risk of bleeding in selected patients and settings.
Why the study?
Does patient self-monitoring of oral anticoagulation reduce thromboembolic events and bleeding compared to clinical setting monitoring in high-risk patients?
Population
High-risk patients requiring oral anticoagulation with vitamin K antagonists
Comparison
Patient self-monitoring of oral anticoagulation… vs Monitoring in clinical settings
Design
Editorial
Authors
Loading...
Self-monitoring of oral anticoagulation is a safe and effective alternative to clinic-based monitoring, reducing thromboembolic events without increasing bleeding risk.
Does patient self-monitoring of oral anticoagulation reduce thromboembolic events and bleeding compared to clinical setting monitoring in high-risk patients?
Self-monitoring of oral anticoagulation is a safe and effective alternative to clinic-based monitoring, reducing thromboembolic events without increasing bleeding risk.
Hanna E. Bloomfield (2012) conducted a review in Patients requiring oral anticoagulation with vitamin K antagonists. Patient self-monitoring of oral anticoagulation (self-management or self-testing) vs. Monitoring in clinical settings was evaluated on Thromboembolic events and bleeding. Self-monitoring of oral anticoagulation reduces thromboembolic events and does not increase the risk of bleeding in selected patients and settings.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: